Skip to main content

Table 1 Characteristics of patients treated by endoscopic submucosal dissection or surgery

From: Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett’s esophageal adenocarcinoma

Characteristics

All patients (n = 41)

SSBEa (n = 30)

LSBEb (n = 11)

SSBE VS. LSBE

P-value

Age, median (range)

67 (39-81)

66 (39-88)

68 (44-79)

0.757

Sex (%)

 Male

32 (78.0)

23 (76.7)

9 (81.8)

1.000

 Female

9 (22.0)

7 (23.3)

2 (18.2)

Body mass index (kg/m2), median (range)

23.0 (16.7-32.6)

23.1 (16.7-32.6)

23.0 (16.7-32.6)

0.596

Tumor size (mm), median (range)

20 (6-60)

17.5 (6-35)

20 (10-60)

0.223

Macroscopic type (%)

 Protruding type

31 (75.6)

25 (83.4)

6 (54.5)

0.164

 Flat type

2 (4.9)

1 (3.3)

1 (9.1)

 Depressed type

8 (19.5)

4 (13.3)

4 (36.4)

Initial treatment (%)

 Endoscopic submucosal dissection (ESD)

13 (31.7)

12 (40.0)

1 (9.1)

0.127

 Operation

28 (68.3)

18 (60.0)

10 (90.9)

Histological type (%)

 Well differentiated (tub1)

21 (51.2)

18 (60.0)

4 (36.4)

0.181

 Moderately differentiated (tub2)

17 (41.5)

11 (36.7)

5 (45.4)

 Poorly differentiated (por)

3 (7.3)

1 (3.3)

2 (18.2)

  1. aSSBE short-segment Barrett’s esophagus
  2. bLSBE long-segment Barrett’s esophagus